TETRALOGIC PHARMACEUTICALS Corp
DelistedCIK 1361248fmd_1GZETBQSQFAK7P8JASB28YPSM7Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2016, 15 periods
| Line item | FY2013 | FY2014 | FY2015 |
|---|---|---|---|
| Total revenues | – | – | 0 |
| Research and development | 10 | 20 | 27 |
| Total operating expenses | 18 | 34 | 45 |
| Operating income | (18) | (34) | (45) |
| Interest expense | 3 | 3 | 6 |
| Interest and investment income | 0 | 0 | 0 |
| Income before taxes | – | – | (50) |
| Income tax expense | – | 0 | – |
| Net income | (20) | (36) | (50) |
| Net income to common shareholders | (23) | (36) | (50) |